首页 > 最新文献

10.01 - Respiratory infections and bronchiectasis最新文献

英文 中文
Long-term efficacy of an inactivated whole particle H5N1 virus against H5N1 highly pathogenic avian influenza virus challenge in cynomolgus monkeys 灭活H5N1全颗粒病毒对食蟹猴H5N1高致病性禽流感病毒攻击的长期疗效
Pub Date : 2022-09-04 DOI: 10.1183/13993003.congress-2022.662
M. Nakayama, H. Ishigaki, N. Thanh Cong, S. Suzuki, H. Ishida, N. Kitagawa, K. Ogasawara, Y. Itoh
{"title":"Long-term efficacy of an inactivated whole particle H5N1 virus against H5N1 highly pathogenic avian influenza virus challenge in cynomolgus monkeys","authors":"M. Nakayama, H. Ishigaki, N. Thanh Cong, S. Suzuki, H. Ishida, N. Kitagawa, K. Ogasawara, Y. Itoh","doi":"10.1183/13993003.congress-2022.662","DOIUrl":"https://doi.org/10.1183/13993003.congress-2022.662","url":null,"abstract":"","PeriodicalId":420846,"journal":{"name":"10.01 - Respiratory infections and bronchiectasis","volume":"241 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133491498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ambulatory management of bronchopleural fistulae secondary to empyema 继发肺气肿支气管胸膜瘘的门诊治疗
Pub Date : 2022-09-04 DOI: 10.1183/13993003.congress-2022.257
J. Davy, P. Tang, M. Burton
{"title":"Ambulatory management of bronchopleural fistulae secondary to empyema","authors":"J. Davy, P. Tang, M. Burton","doi":"10.1183/13993003.congress-2022.257","DOIUrl":"https://doi.org/10.1183/13993003.congress-2022.257","url":null,"abstract":"","PeriodicalId":420846,"journal":{"name":"10.01 - Respiratory infections and bronchiectasis","volume":"39 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133639379","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The microbiology of adult pleural infection in an Egyptian hospital 埃及一家医院成人胸膜感染的微生物学分析
Pub Date : 2022-09-04 DOI: 10.1183/13993003.congress-2022.332
M. Hassan, M. Gadallah, A. Elshazly, B. El-shaarawy, A. Sadaka
{"title":"The microbiology of adult pleural infection in an Egyptian hospital","authors":"M. Hassan, M. Gadallah, A. Elshazly, B. El-shaarawy, A. Sadaka","doi":"10.1183/13993003.congress-2022.332","DOIUrl":"https://doi.org/10.1183/13993003.congress-2022.332","url":null,"abstract":"","PeriodicalId":420846,"journal":{"name":"10.01 - Respiratory infections and bronchiectasis","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132106944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CoV-Sym: The development of a psychometrically validated patient reported outcome measure for COVID-19 CoV-Sym:开发一种经心理测量学验证的COVID-19患者报告结果测量方法
Pub Date : 2022-09-04 DOI: 10.1183/13993003.congress-2022.3312
C. Lythgoe, A. Rowe, O. Aiyegbusi, L. Chambers, F. Sherratt, J. Wood, B. Young, D. Wootton
Background: Patient reported outcome measures (PROMs) provide a standardised method to capture patient perspectives which can be used in comparative effectiveness research to inform the evaluation of treatment. Thus far, PROMs have focussed on the long-term sequelae of COVID-19 rather than the acute illness and initial recovery period. Aim(s): To design a psychometrically validated COVID-19 specific PROM to be used in the acute and recovery phase of illness. Method(s): A review of existing literature, evaluation of existing PROMs, input from local experts (n=15) and in-depth qualitative concept elicitation interviews with patients (n=8) were used to create a conceptual framework which informed the generation of items included in the PROM. Cognitive interviews with patients (n=8) were then used to develop and refine the items for inclusion in the PROM and confirm the content and face validity of the draft tool. A nominal group meeting of the expert panel (n=6) was held to confirm the final items for inclusion. Result(s): The CoV-Sym PROM consists of 19 domains and 44 items which are scored using a five-point Likert scale to enable objective measurement of patients' symptomatic recovery from acute COVID-19 illness. Questions address physical, psychological and social domains. Cognitive interviews revealed acceptable content and face validity. Conclusion(s): With the involvement of both patients and experts in the development and validation process, we have created the first COVID-19 specific PROM to measure patient's symptomatic recovery from acute COVID-19 infection. It is ready for further psychometric testing to confirm reliability and responsiveness, the results of which will be presented.
背景:患者报告的结果测量(PROMs)提供了一种标准化的方法来捕捉患者的观点,可用于比较有效性研究,以告知治疗评估。到目前为止,prom关注的是COVID-19的长期后遗症,而不是急性疾病和初始恢复期。目的:设计一种心理测量学验证的COVID-19特异性PROM,用于疾病的急性期和恢复期。方法:通过对现有文献的回顾、对现有PROM的评估、当地专家的意见(n=15)和对患者进行深入的定性概念启发访谈(n=8),建立了一个概念框架,该框架为PROM中包含的项目的生成提供了信息。然后使用与患者的认知访谈(n=8)来开发和完善纳入PROM的项目,并确认草稿工具的内容和面效度。举行了一次专家小组名义上的小组会议(n=6),以确认列入的最后项目。结果:CoV-Sym PROM由19个域和44个项目组成,采用五点李克特量表进行评分,以客观衡量患者急性COVID-19疾病的症状恢复情况。问题涉及身体,心理和社会领域。认知访谈揭示了可接受的内容和面孔效度。结论:在患者和专家共同参与的开发和验证过程中,我们创建了第一个COVID-19特异性PROM,用于测量患者急性COVID-19感染后的症状恢复。它已准备好进行进一步的心理测量测试,以确认可靠性和反应性,其结果将被呈现。
{"title":"CoV-Sym: The development of a psychometrically validated patient reported outcome measure for COVID-19","authors":"C. Lythgoe, A. Rowe, O. Aiyegbusi, L. Chambers, F. Sherratt, J. Wood, B. Young, D. Wootton","doi":"10.1183/13993003.congress-2022.3312","DOIUrl":"https://doi.org/10.1183/13993003.congress-2022.3312","url":null,"abstract":"Background: Patient reported outcome measures (PROMs) provide a standardised method to capture patient perspectives which can be used in comparative effectiveness research to inform the evaluation of treatment. Thus far, PROMs have focussed on the long-term sequelae of COVID-19 rather than the acute illness and initial recovery period. Aim(s): To design a psychometrically validated COVID-19 specific PROM to be used in the acute and recovery phase of illness. Method(s): A review of existing literature, evaluation of existing PROMs, input from local experts (n=15) and in-depth qualitative concept elicitation interviews with patients (n=8) were used to create a conceptual framework which informed the generation of items included in the PROM. Cognitive interviews with patients (n=8) were then used to develop and refine the items for inclusion in the PROM and confirm the content and face validity of the draft tool. A nominal group meeting of the expert panel (n=6) was held to confirm the final items for inclusion. Result(s): The CoV-Sym PROM consists of 19 domains and 44 items which are scored using a five-point Likert scale to enable objective measurement of patients' symptomatic recovery from acute COVID-19 illness. Questions address physical, psychological and social domains. Cognitive interviews revealed acceptable content and face validity. Conclusion(s): With the involvement of both patients and experts in the development and validation process, we have created the first COVID-19 specific PROM to measure patient's symptomatic recovery from acute COVID-19 infection. It is ready for further psychometric testing to confirm reliability and responsiveness, the results of which will be presented.","PeriodicalId":420846,"journal":{"name":"10.01 - Respiratory infections and bronchiectasis","volume":"29 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133029774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
what relationship between eosinophilia and covid19 prognosis? 嗜酸性粒细胞增多与covid - 19预后有何关系?
Pub Date : 2022-09-04 DOI: 10.1183/13993003.congress-2022.1318
I. Ketata, S. Majdoub Fehri, W. Madi, R. Sellami, H. Kwass
{"title":"what relationship between eosinophilia and covid19 prognosis?","authors":"I. Ketata, S. Majdoub Fehri, W. Madi, R. Sellami, H. Kwass","doi":"10.1183/13993003.congress-2022.1318","DOIUrl":"https://doi.org/10.1183/13993003.congress-2022.1318","url":null,"abstract":"","PeriodicalId":420846,"journal":{"name":"10.01 - Respiratory infections and bronchiectasis","volume":"42 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133553694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Developing a Long-COVID follow-up protocol in a Portuguese tertiary hospital 在葡萄牙三级医院制定covid - 19长期随访方案
Pub Date : 2022-09-04 DOI: 10.1183/13993003.congress-2022.2784
G. Canelas, M. Gomes, C. Nuñes Silva, A. Sarmento, M. Tavares
{"title":"Developing a Long-COVID follow-up protocol in a Portuguese tertiary hospital","authors":"G. Canelas, M. Gomes, C. Nuñes Silva, A. Sarmento, M. Tavares","doi":"10.1183/13993003.congress-2022.2784","DOIUrl":"https://doi.org/10.1183/13993003.congress-2022.2784","url":null,"abstract":"","PeriodicalId":420846,"journal":{"name":"10.01 - Respiratory infections and bronchiectasis","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133558538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Particularities of post-tuberculosis bronchiectasis 结核后支气管扩张的特点
Pub Date : 2022-09-04 DOI: 10.1183/13993003.congress-2022.3961
S. Ben Sassi, H. Rouis, C. Moussa, M. Bougacha, A. Khattab, I. Khouaja, L. Bayahi, I. Zendah, S. Maȃlej
{"title":"Particularities of post-tuberculosis bronchiectasis","authors":"S. Ben Sassi, H. Rouis, C. Moussa, M. Bougacha, A. Khattab, I. Khouaja, L. Bayahi, I. Zendah, S. Maȃlej","doi":"10.1183/13993003.congress-2022.3961","DOIUrl":"https://doi.org/10.1183/13993003.congress-2022.3961","url":null,"abstract":"","PeriodicalId":420846,"journal":{"name":"10.01 - Respiratory infections and bronchiectasis","volume":"22 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115548957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical performance evaluation of an anti-SARS-CoV-2 IgG enzyme-linked immunosorbent assay 抗sars - cov -2 IgG酶联免疫吸附试验的临床性能评价
Pub Date : 2022-09-04 DOI: 10.1183/13993003.congress-2022.4612
J. Moore, L. Robertson, T. Ferguson, E. Cain, J. Goodman, C. Colley, M. Orr, T. Moore
{"title":"Clinical performance evaluation of an anti-SARS-CoV-2 IgG enzyme-linked immunosorbent assay","authors":"J. Moore, L. Robertson, T. Ferguson, E. Cain, J. Goodman, C. Colley, M. Orr, T. Moore","doi":"10.1183/13993003.congress-2022.4612","DOIUrl":"https://doi.org/10.1183/13993003.congress-2022.4612","url":null,"abstract":"","PeriodicalId":420846,"journal":{"name":"10.01 - Respiratory infections and bronchiectasis","volume":"342 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115578042","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of severe lymphopenia on outcome of patients with pneumonia and positive pneumococcal urinary antigen 严重淋巴细胞减少症对肺炎链球菌尿抗原阳性患者预后的影响
Pub Date : 2022-09-04 DOI: 10.1183/13993003.congress-2022.822
L. A. Ruiz Iturriaga, L. Serrano Fernandez, S. Pérez-Fernández, S. Castro Quintas, A. Urrutia Gajate, B. González Quero, A. Rezola Carasusan, A. Artaraz Ereño, A. Gómez Bonilla, P. P. España Yandiola, R. Zalacain Jorge
{"title":"Impact of severe lymphopenia on outcome of patients with pneumonia and positive pneumococcal urinary antigen","authors":"L. A. Ruiz Iturriaga, L. Serrano Fernandez, S. Pérez-Fernández, S. Castro Quintas, A. Urrutia Gajate, B. González Quero, A. Rezola Carasusan, A. Artaraz Ereño, A. Gómez Bonilla, P. P. España Yandiola, R. Zalacain Jorge","doi":"10.1183/13993003.congress-2022.822","DOIUrl":"https://doi.org/10.1183/13993003.congress-2022.822","url":null,"abstract":"","PeriodicalId":420846,"journal":{"name":"10.01 - Respiratory infections and bronchiectasis","volume":"16 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115599218","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CLINICAL PHENOTYPES OF COVID-19 PNEUMONIA: different phases of viral process or really different states? COVID-19肺炎的临床表型:病毒过程的不同阶段还是真正不同的状态?
Pub Date : 2022-09-04 DOI: 10.1183/13993003.congress-2022.1734
Y. Huba, K. Bielosludtseva, L. Konopkina, T. Pertseva
{"title":"CLINICAL PHENOTYPES OF COVID-19 PNEUMONIA: different phases of viral process or really different states?","authors":"Y. Huba, K. Bielosludtseva, L. Konopkina, T. Pertseva","doi":"10.1183/13993003.congress-2022.1734","DOIUrl":"https://doi.org/10.1183/13993003.congress-2022.1734","url":null,"abstract":"","PeriodicalId":420846,"journal":{"name":"10.01 - Respiratory infections and bronchiectasis","volume":"55 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114827569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
10.01 - Respiratory infections and bronchiectasis
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1